Shares of Caliper Life Sciences rose 16.8 percent for the five-day trading week ended Tuesday after reporting last week that its second-quarter revenues rose 45 percent (see related article). The firm also said that it had received a key patent for its optical imaging IP estate.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.